For the Inventor, By the Inventor

Enter inventor name

Shanghai, China

Kaixian Chen

USPTO Granted Patents = 28 (Patent Applications = 11)

CIPO Patents = 12 (Patent Applications = 4)

EPO Patents = 14 (Patent Applications = 24)

Average Co-Inventor Count = 8.9

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Hong Kong, CN (2016)
Shanghai, CN (2008 - 2024)

Company Filing History:

21 out of 3,086

Chinese Academy of Sciences

Wigen Biomedicine Technology (shanghai) Co., Ltd.

Hong Kong Baptist University

Kingsound & Partner

Cisen Pharmaceutical Co., Ltd.

Shanghai University of Traditional Chinese

7. 1 out of 207

Fudan University

Nanjing Pailexing Pharmaceutical Technology Ltd.

Shanghai Lead Discovery Pharmaceuticals Limited Company

where one patent can have more than one assignee

Years Active: 2008-2024

where 'Filed Patents' based on already Granted Patents

28 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12152017 - Ketoamide compound and preparation method, pharmaceutical composition, and use thereof (2024-11-26),

2. 12145923 - Tetrahydroisoquinoline compound, preparation method therefor, pharmaceutical composition containing same, and use thereof (2024-11-19),

3. 11873292 - Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof (2024-01-16),

4. 11730742 - Pharmaceutical use of thiophene [3,2-d] pyrimidine-4-ketone compound (2023-08-22),

5. 11529321 - Use of aminomethylenecyclohexane-1,3-dione compound (2022-12-20),

6. 11319303 - Compound used as autophagy regulator, and preparation method therefor and uses thereof (2022-05-03),

7. 11021457 - Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereof (2021-06-01),

8. 10966996 - extract, preparation method for same, and use thereof in sugar reduction, weight loss, and lipid reduction (2021-04-06),

9. 10927107 - Phenyl [a]indole[2,3-g]quinolizine compounds, preparation method therefor, pharmaceutical composition, and applications thereof (2021-02-23),

10. 10875883 - Method for synthesizing novel chiral ligand, metal chelate, a variety of non-natural amino acids, maraviroc and key intermediate thereof (2020-12-29),

11. 10836743 - Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof (2020-11-17),

12. 10800776 - Fluorine-containing triazolopyridine, and manufacturing method, pharmaceutical composition, and application thereof (2020-10-13),

13. 10640514 - Polymorph of DPPIV inhibitor maleate and preparation method therefor (2020-05-05),

14. 10618900 - 5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof (2020-04-14),

15. 10611774 - Salt form of DPPIV inhibitor and preparation method thereof (2020-04-07),

Title: Kaixian Chen - Innovative Inventor from Shanghai

Introduction: Kaixian Chen is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Kaixian Chen holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a career spanning over two decades, Kaixian Chen has worked with leading research institutions and multinational companies, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Kaixian Chen has collaborated with top universities, research institutions, and tech companies worldwide, fostering a culture of innovation and knowledge-sharing that has led to numerous successful projects and inventions.

Conclusion: Kaixian Chen's passion for innovation, coupled with his relentless drive to push the boundaries of technology, has solidified his reputation as a visionary inventor in the global innovation landscape.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…